CD4 and HIV-1 infection: IRF-1 expression was then evaluated after de novo HIV-1 infection of primary human CD4+ T cells; an early 2- to 3-fold stimulation of IRF-1 expression, was followed by an inhibition of IRF-1 expression to levels present in uninfected cells (Fig. 7D).